Go to deals
Private Equity | Healthcare

Makker Hoortoestellen has completed a purchase price allocation

January 2025 — NewPort Capital has acquired Makker Hoortoestellen. Following the successful completion of the transaction, NewPort Capital has been required to perform a purchase price allocation (PPA). The firm sought support during the post-acquisition phase to address key financial reporting, valuation and integration-related requirements associated with the investment.

Makker Hoortoestellen is a Netherlands-based independent hearing care retailer specializing in hearing aids, hearing tests, hearing protection, accessories and related aftercare services. The company operates a growing network of physical hearing care stores across the Netherlands, supported by an online store and digital hearing test offering.

NewPort Capital is an Amsterdam-based independent private equity firm focused on investing in Dutch mid-market companies with strong management teams and growth potential. The firm partners with entrepreneurs across sectors including software, technology, business services, manufacturing, food and packaging, supporting portfolio companies through growth capital, buy-and-build strategies, international expansion and operational professionalization.

Our role in the transaction

Oaklins’ team in the Netherlands advised NewPort Capital during the post-transaction phase and performed a PPA in accordance with Dutch generally accepted accounting principles (Dutch GAAP).

Talk to the deal team

Costas Constantinou

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Related deals

Comtax has been acquired by Ryan
Private Equity | Business Support Services | TMT

Comtax has been acquired by Ryan

Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.

Learn more
Cibus has acquired Aweta from Standard Investment
Private Equity | Agriculture | Industrial Machinery & Components

Cibus has acquired Aweta from Standard Investment

Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.

Learn more
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Healthcare

Katalyst Diagnostics has been acquired by Cruinn Diagnostics

Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.

Learn more